BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15638816)

  • 1. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure.
    Berger R; Huelsmann M; Strecker K; Moertl D; Moser P; Bojic A; Pacher R
    Eur J Clin Invest; 2005 Jan; 35(1):24-31. PubMed ID: 15638816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB; O'Brien RJ; Demme B; Davies JE; Ng LL
    Clin Sci (Lond); 2004 Sep; 107(3):309-16. PubMed ID: 15182235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism.
    Kiely DG; Kennedy NS; Pirzada O; Batchelor SA; Struthers AD; Lipworth BJ
    Respir Med; 2005 Oct; 99(10):1286-91. PubMed ID: 16099151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure.
    Vrtovec B; Delgado R; Zewail A; Thomas CD; Richartz BM; Radovancevic B
    Circulation; 2003 Apr; 107(13):1764-9. PubMed ID: 12665499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice.
    Buckley MG; Marcus NJ; Yacoub MH
    Clin Sci (Lond); 1999 Dec; 97(6):689-95. PubMed ID: 10585896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of heart failure using urinary natriuretic peptides.
    Ng LL; Geeranavar S; Jennings SC; Loke I; O'Brien RJ
    Clin Sci (Lond); 2004 Feb; 106(2):129-33. PubMed ID: 13678415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of natriuretic Peptide levels to predict mortality in adults with congenital heart disease.
    Giannakoulas G; Dimopoulos K; Bolger AP; Tay EL; Inuzuka R; Bedard E; Davos C; Swan L; Gatzoulis MA
    Am J Cardiol; 2010 Mar; 105(6):869-73. PubMed ID: 20211335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
    Gwechenberger M; Pacher R; Berger R; Zorn G; Moser P; Stanek B; Huelsmann M
    J Heart Lung Transplant; 2005 Dec; 24(12):2190-5. PubMed ID: 16364870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction].
    Mazurek W; Salomon P
    Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.
    Gwechenberger M; Hülsmann M; Berger R; Graf S; Springer C; Stanek B; Pacher R
    J Heart Lung Transplant; 2004 Jul; 23(7):839-44. PubMed ID: 15261178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.